Skip to main content
News 3 min read

KLDX Launches Malaysia’s First Tokenised Primary Offering of a Shariah-Compliant Fixed Income Product

02 Apr 2024

Like this article? Share it

Kuala Lumpur, 1 April 2024 – Kapital DX Sdn Bhd (KLDX), an innovative multi-asset fundraising and investment platform, is pleased to announce the issuance of its first product, a RM150 million tokenised primary offering of a shariah-compliant fixed income product (i-INT Programme) by Integra Healthcare Technology Sdn Bhd (Integra).

The Programme offers a compelling 5-year tenor with an enticing profit rate of up to 10% per annum. Tranche 1 of the i-INT Programme, amounting to RM29 million, has been fully subscribed through institutional participation.

This groundbreaking venture marks a major milestone for both KLDX and the Malaysian capital markets landscape, showcasing the transformative potential of blockchain technology in the realm of fundraising and investment. Through blockchain technology, KLDX enables fractional ownership of a wide array of assets, making private market investments accessible to a wider audience. This strategic move is designed to bridge the funding gap for growth to late-stage companies, facilitate project financing, and expand the range of available asset classes through tokenisation.

Selvarany Rasiah, Founder and CEO of KLDX, expressed excitement about the historic issuance, stating, “We are pleased to welcome Integra, our inaugural product for KLDX. This issuance not only reflects KLDX’s dedication in shaping Malaysia’s asset tokenisation landscape but also demonstrates our commitment to supporting impactful projects that benefits the community. Our platform is designed to catalyse economic growth by facilitating accessible, efficient fundraising for businesses, and at the same time, offering investors a gateway to diverse, high-yield private market assets. We are committed to fostering a vibrant ecosystem where businesses can thrive on robust investments and where investors can achieve superior returns, thereby driving mutual prosperity in our economy.‘’

“We also like to extend our appreciation to the Securities Commission Malaysia (SC) for their progressive approach in facilitating and ensuring a regulated environment for innovative platforms like KLDX,” she added.

Integra, a healthcare solutions provider, develops, owns and manages specialist rehabilitation and healthcare centres. Its first flagship rehabilitation facility achieved a remarkable 75% occupancy rate within 9 months of becoming operational, showcasing its dedication to excellence. Integra is now raising funds to set up four (4) new rehabilitation centres.

“We are pleased to partner with KLDX for this historic milestone in the Malaysian financial landscape. The i-INT Programme represents a significant step forward for Integra as we continue our mission to expand access to rehabilitation services for a broader community. The support and collaboration from KLDX underscore their commitment to innovative and impactful projects, and we look forward to a successful journey together”, Dr. Nor Azira Ismail, CEO of Integra, remarked enthusiastically.

Tranche 2 of the i-INT Programme is now open. To learn more about this issuance, sign up for an account at and reach out to KLDX today.


About KLDX

KLDX is the first Initial Exchange Offering platform in Malaysia, registered and regulated by the Securities Commission Malaysia. KLDX is a multi-asset  fundraising platform that helps private companies raise funds  through the issuance of security tokens and democratise investors’ access to private markets. Among investors in KLDX include Malaysia Debt Ventures Berhad (MDV), a subsidiary of Minister of Finance (Incorporated).

About Integra Healthcare

Integra is a company incorporated in Malaysia with a vision is to become a leading provider of innovative and integrated healthcare solutions that promote well-being, rehabilitation, and improved quality of life for individuals. It strives to be at the forefront of technology adoption in the healthcare sector, empowering both patients and healthcare professionals with cutting-edge solutions and personalised care.

For media enquiries, please contact:

Name: Taraec Hussein


Speak to Us

    * Required Field

    By using this site, you agree to our Privacy Policy and Platform Terms and Conditions.